Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Enrolling By Invitation NCT06208878

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Conditions: Hematologic Malignancy, Solid Malignancy

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 70

Sponsor: CRISPR Therapeutics AG

Location: City of Hope Duarte California

Summary

This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies

Eligibility Criteria

Inclusion Criteria: * Able to understand and comply with protocol-required study procedures and voluntarily sign and date a written informed consent document. * Must have received CRISPR CAR T cellular therapy. Exclusion Criteria: * There are no specific exclusion criteria.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06208878). StuddyBuddy aggregates publicly available trial information.